Q&A: What Medicare covering TriClip means for patients | Surgeons make history with heart reanimation | Radial PCI on the rise

The tricuspid valve has been at the center of several key policy shifts in recent years. In fact, Medicare now covers both T-TEER and TTVR when performed with FDA-approved devices. We spoke to interventional cardiologist Jason H. Rogers, MD, to learn more about how this momentum has impacted patient care. 

“This innovation was born out of necessity,” one surgeon explained. “We were determined to find a way to help the smallest and sickest children who previously had no access to DCD heart donation.” 

In fact, more than 55% of all PCI cases in 2022 were performed using radial access. Cardiologists are sure to be keeping a close eye on this trend as time goes on.

Allen Taylor, MD, thinks AI-powered plaque evaluations can make a substantial impact on patient care. 

Targeting high-risk patients with single-pill combination therapies, also known as polypills, could change healthcare on a global scale, according new data published in the Journal of the American College of Cardiology. 

When older patients undergo SAVR with concomitant procedures, it increases their short- and long-term risks of mortality. Should this influence care teams to consider more transcatheter treatments? 

The CorWave technology is unlike other left ventricular assist devices, working in harmony with the patient's heartbeat and making adjustments as needed. 

The cuffless technology, which has already gained CE mark approval, should make its U.S. debut in 2026.

Statins appear to be the most impactful for patients diagnosed with hypertension or cerebrovascular disease.

AI can improve the quality of remotely delivered care while simultaneously defending privacy and security for the telehealth patient. 

Determining the source of an unprovoked seizure in young patients who have no prior history can be challenging, and guidelines for doing so are somewhat conflicting.